Asymptotics for the Capacity of a Condenser with Variable Potential Levels

2020 ◽  
Vol 61 (4) ◽  
pp. 626-631
Author(s):  
V. N. Dubinin
Author(s):  
Л.М. Энеева

В работе исследуется обыкновенное дифференциальное уравнение дробного порядка, содержащее композицию дробных производных с различными началами, с переменным потенциалом. Рассматриваемое уравнение выступает модельным уравнением движения во фрактальной среде. Для исследуемого уравнения доказана априорная оценка решения смешанной двухточечной краевой задачи. We consider an ordinary differential equation of fractional order with the composition of leftand right-sided fractional derivatives, and with variable potential. The considered equation is a model equation of motion in fractal media. We prove an a priori estimate for solutions of a mixed two-point boundary value problem for the equation under study.


2020 ◽  
Vol 17 (06) ◽  
pp. 2050085
Author(s):  
José Antonio Belinchón ◽  
Danae Polychroni

We study a string inspired cosmological with variable potential through the Lagrangian invariance method in order to determine the form of the potential. We have studied four cases by combining the different fields, that is, the dilaton [Formula: see text] the potential [Formula: see text] the [Formula: see text]-field and the matter field (a perfect fluid). In all the studied cases, we found that the potential can only take two possible forms: [Formula: see text] and [Formula: see text] where [Formula: see text] and [Formula: see text] are numerical constants. We conclude that when we take into account the Kalb–Ramond field, i.e. the [Formula: see text]-field, then it is only possible to get a constant potential, [Formula: see text] Nevertheless, if this field is not considered, then we get two possible solutions for the potential: [Formula: see text] and [Formula: see text] In all the cases, if the potential is constant, [Formula: see text] then we get a de Sitter like solution for the scale factor of the metric, [Formula: see text], which verifies the [Formula: see text]-duality property, while if the potential varies, then we get a power-law solution for the scale factor, [Formula: see text] [Formula: see text]


Minerals ◽  
2020 ◽  
Vol 10 (9) ◽  
pp. 814
Author(s):  
Dariusz Ciszewski ◽  
Urszula Aleksander-Kwaterczak

The study attempted to map and predict the remobilization of metals in a floodplain which had been heavily affected by long-term Zn–Pb mining. This research, based on Zn, Cd, Pb, Ca and Fe speciation, mineralogy and the stratigraphy of sediments which had accumulated over the distance of a dozen or so km from the mine, revealed variable potential for metal mobilization. The results suggest that a drop in the water table, something to be expected after the closure of a mine, would be accompanied by a decrease in the pH of the river water and can induce the remobilization of metals associated with carbonates and exchangeable cations over the short-reach downstream of the mine. However, the mobilization of contaminants may be impeded by the alkaline, impermeable stratum of loams, which play a pivotal role in maintaining anaerobic conditions and buffering the acidity resulting from the partial degradation of sulfides. Based on the findings of the study, it can be expected that the intrinsic attenuation will limit the need for remediation works, although monitoring river water quality is recommended to determine the need for any intervention in cases where permissible quality values have been exceeded over a longer period. Results of this research can be useful as a reference for remediation works planned in other contaminated river systems experiencing water table lowering, where the mobilization of contaminants as a consequence of sediment oxidization can be expected.


2019 ◽  
Vol 13 ◽  
pp. 117955491983392 ◽  
Author(s):  
Joelle El-Amm ◽  
Jeanny B Aragon-Ching

Non-metastatic castration-resistant prostate cancer (nmCRPC) is a heterogeneous disease with variable potential in developing into overt metastases. It is an area of increased unmet need in advanced prostate cancer and for which there had been no great treatments until recent US Food and Drug Administration (FDA) approval of 2 novel anti-androgens apalutamide and enzalutamide, which were both approved given benefit in metastasis-free survival. Early data on the use of darolutamide, another novel anti-androgen, are also explored. This review discusses the pivotal trials that led to the approval of apalutamide and enzalutamide in the nmCRPC setting and discusses the key promises and challenges with the use of these agents.


Sign in / Sign up

Export Citation Format

Share Document